Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q1 · 4,6 OA 1 matched articles ESCI

Journal detail

Neuro-Oncology Advances

Publisher
Oxford University Press
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 26322498
Scopus 1,421 SJR
Scopus Q1 SJR Q
WoS Q1 JCR Q
WoS 4,6 JIF
Scopus 42 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 1,421
  • Quartile Q1
  • H-Index 42
  • Cites/doc 4,02
  • Docs (3y) 551
  • Cites (3y) 2.238

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q1
  • JIF 4,6
  • 5Y JIF 4,4
  • JCI 0,98

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Neurology (clinical) Q1
  • Oncology Q1
  • Surgery Q1

Areas

  • Medicine

WoS categories

  • Oncology | Clinical Neurology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q1 1,421 4,6 4,4 0,98 Q2 42
2024 Q1 Q1 1,472 4,1 4,3 1,02 Q1 33
2023 Q1 Q1 1,315 3,7 3,9 0,76 Q2 33
2022 Q1 1,052 3,5 3,6 0,59 Q3 33
2021 33
2020 33
2019 33

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 CLINICAL NEUROLOGY ESCI Q1 Q2 48/296
2025 ONCOLOGY ESCI Q2 Q2 101/333
2024 CLINICAL NEUROLOGY ESCI Q1 Q2 51/286
2024 ONCOLOGY ESCI Q2 Q1 91/328
2023 CLINICAL NEUROLOGY ESCI Q1 Q2 63/280
2023 ONCOLOGY ESCI Q2 Q2 104/322
2022 CLINICAL NEUROLOGY ESCI Q3
2022 ONCOLOGY ESCI Q3